Panagora Asset Management Inc Cv Sciences, Inc. Transaction History

Panagora Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$1.6 - $7.13 $65,680 - $292,686	-41,050 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$0.41 - $2.41 $76,277 - $448,361	-186,042 Reduced 81.92%	41,050 $68,000
Q4 2017 Feb 14, 2018	BUY	$0.18 - $0.62 $15,001 - $51,672	83,343 Added 57.98%	227,092 $140,000
Q3 2017 Nov 14, 2017	BUY	$0.22 - $0.32 $31,624 - $45,999	143,749	143,749 $37,000

Ticker CVSI
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 147,794,000
Market Cap $7.39M
Description
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense,...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.